SEARCH
Therapeutic Efficacy as patent criteria of India's new guidelines for drugs
Mint
2018-02-16
Views
0
Description
Share / Embed
Download This Video
Report
The reactions shows widely contradicting views from innovator companies, generic industry and healthcare groups on two major points of new guidelines over India's new patent examination guidelines for drugs and pharmaceuticals.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x6ev00a" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
05:06
From the newsroom: India's patents problem
06:02
Dictionary words in software patent guidelines puzzle industry
00:47
India's own malaria drug
00:58
A list of drugs that may go off the chemists’ shelves
04:46
From the newsroom: How to price drugs?
02:40
Soon, compulsory licenses for diabetes drugs
03:00
Dynamite fishing, drugs, threaten Myanmar's 'sea gypsies'
00:00
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
00:00
Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
00:00
Digitalist Forum with MINT & SAP
00:00
Transformation Agenda 2020 : India's changing urban landscape
03:14
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga